(Q33895538)

29 July 2017

1 reference

title

Role of LH and FSH in ovarian function (English)

1 reference

29 July 2017

Howles CM

1

1 reference

29 July 2017

publication date

1 March 2000

1 reference

Molecular and Cellular Endocrinology

29 July 2017

published in

1 reference

29 July 2017

volume

161

1 reference

29 July 2017

issue

1-2

1 reference

29 July 2017

page(s)

25-30

1 reference

Pregnancy after treatment with three recombinant gonadotropins

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Ovarian response to recombinant human follicle-stimulating hormone in luteinizing hormone-depleted women: examination of the two cell, two gonadotropin theory

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin for superovulation and in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Steroid production in cultured thecal cells obtained from human ovarian follicles

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Relationship between Saturation of LH Receptors and Steroidogenic Response in Isolated Rat Granulosa Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

The ovarian androgen producing cells: a review of structure/function relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Follicular development and early luteal function of conception and non-conceptional cycles after human in-vitro fertilization: endocrine correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Treatment and causes of female infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Recombinant human luteinising hormone to mimic mid-cycle LH surge

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Medical hypophysectomy: II. Variability of ovarian response to gonadotropin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Successful induction ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Insulin-like growth factor-I selectively stimulates cholesterol side-chain cleavage expression in ovarian theca-interstitial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Hypersecretion of luteinising hormone, infertility, and miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

The use of pure follicle-stimulating hormone for ovulation induction in normal ovulatory women in an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

A Receptor-Like Testosterone-Binding Protein in Ovaries from Estrogen-Stimulated Hypophysectomized Immature Female Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

The luteinizing hormone surge--the final stage in ovulation induction: modern aspects of ovulation triggering.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Comparison of the effects of HMG or pure FSH stimulation during suppression with an LHRH agonist analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Oocyte maturation inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Hormonal regulation of the growth and steroidogenic function of human granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2899%2900219-1

7 January 2021

10.1016/S0303-7207(99)00219-1

Identifiers

DOI

1 reference

29 July 2017

1 reference